Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes

被引:26
|
作者
Ninomiya, Hiroyo [1 ]
Katakami, Naoto [1 ,2 ]
Sato, Ihoko [1 ]
Osawa, Saeko [1 ]
Yamamoto, Yuichi [1 ]
Takahara, Mitsuyoshi [1 ,3 ]
Kawamori, Dan [1 ]
Matsuoka, Taka-aki [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Metab & Atherosclerosis, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Osaka, Japan
关键词
Skin autofluorescence; Advanced glycation end products; Endothelial dysfunction; Atherosclerosis; Diabetes; INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CORONARY-ARTERY-DISEASE; BRACHIAL-ARTERY; ENDOTHELIAL FUNCTION; SURROGATE MARKER; AUTOFLUORESCENCE; RISK; COMPLICATIONS; GUIDELINES;
D O I
10.5551/jat.44859
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: The level of accumulated advanced glycation end-products (AGEs) in the skin has been shown to predict the risk of complications in patients with diabetes mellitus (DM). Recently, the level of accumulated fluorescent AGEs in the skin has become measurable as skin autofluorescence (skin AF) using a non-invasive apparatus, autofluorescence reader. The purpose of this study was to evaluate the association between skin AF and the subclinical atherosclerosis markers, especially endothelial dysfunction, in patients with DM. Methods: We enrolled 140 Japanese subjects with DM who attended Osaka University Hospital, and measured the skin level of AGEs by skin AF and three subclinical atherosclerosis markers: endothelial function by flowmediated vasodilation, FMD; carotid intima-media thickness, IMT; and brachial-ankle pulse wave velocity, baPWV. Results: FMD was significantly associated with skin AF (r =-0.259, p= 0.002). Furthermore, a stepwise multivariate regression analysis revealed that skin AF was an independent determinant of FMD (beta=-0.180, p= 0.038). Although there were significant associations between skin AF and maximum carotid intima-media thickness (max-IMT)(r = 0.298, p< 0.001) as well as baPWV (r = 0.284, p= 0.001) in univariate analysis, skin AF was not an independent determinant of either carotid max-IMT or baPWV after adjustment for conventional cardiovascular risk factors. Receiver-operating characteristic curve analysis revealed that skin AF can identify the subjects whose FMD, max-IMT, and baPWV were completely within the normal range (C-statistics, 0.73; 95% confidence interval, 0.61-0.84; p< 0.001). Conclusions: Skin AF was independently associated with FMD as an indicator of endothelial dysfunction, and can be utilized as a screening marker of atherosclerosis in Japanese patients with DM.
引用
收藏
页码:1274 / 1284
页数:11
相关论文
共 50 条
  • [31] Advanced Glycation End-products Attenuate Abdominal Aortic Aneurysms in Diabetes
    Zheng, Xiaoya
    Li, Yankui
    Guo, Jia
    Shoji, Takahiro
    Chen, Xiaofeng
    Zhao, Sihai
    Miyata, Masaaki
    Xu, Baohui
    Dalman, Ronald
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [32] Upregulation of aspartoacylase seen in diabetes is due to advanced glycation end-products
    Surendran, Sankar
    MEDICAL HYPOTHESES, 2007, 68 (04) : 926 - 926
  • [33] Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy
    Chiarelli, F
    Mansour, M
    Verrotti, A
    DIABETES NUTRITION & METABOLISM, 2000, 13 (04) : 192 - 199
  • [34] Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients
    Li, Jinze
    Roshelli Baker, Jacqueline
    Aglago, Elom K.
    Zhao, Zhiwei
    Jiao, Li
    Freisling, Heinz
    Hughes, David J.
    Eriksen, Anne Kirstine
    Tjonneland, Anne
    Severi, Gianluca
    Katzke, Verena
    Kaaks, Rudolf
    Schulze, Matthias B.
    Masala, Giovanna
    Pala, Valeria
    Pasanisi, Fabrizio
    Tumino, Rosario
    Padroni, Lisa
    Vermeulen, Roel C. H.
    Gram, Inger T.
    Braaten, Tonje
    Jakszyn, Paula Gabriela
    Sanchez, Maria-Jose
    Gomez-Gomez, Jesus-Humberto
    Moreno-Iribas, Conchi
    Amiano, Pilar
    Papier, Keren
    Weiderpass, Elisabete
    Huybrechts, Inge
    Heath, Alicia K.
    Schalkwijk, Casper
    Jenab, Mazda
    Fedirko, Veronika
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 1982 - 1995
  • [35] Advanced glycation end-products in diabetes mellitus and renal failure - Foreword
    Maeda, K
    Shinzato, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 1 - 1
  • [36] Advanced glycation end-products in patients with chronic alcohol misuse
    Kalousova, M
    Zima, T
    Popov, P
    Spacek, P
    Braun, M
    Soukupova, J
    Pelinkova, K
    Kientsch-Engel, R
    ALCOHOL AND ALCOHOLISM, 2004, 39 (04): : 316 - 320
  • [37] Advanced glycation end-products: new markers of renal dysfunction in patients with chronic heart failure
    Raposeiras-Roubin, Sergio
    Rodino-Janeiro, Bruno K.
    Grigorian-Shamagian, Lilian
    Moure-Gonzalez, Maria
    Seoane-Blanco, Ana
    Varela-Roman, Alfonso
    Alvarez, Ezequiel
    Gonzalez-Juanatey, Jose R.
    MEDICINA CLINICA, 2011, 136 (12): : 513 - 521
  • [38] Association of Bone Turnover Markers and Advanced Glycation End Products in Type 1 Diabetes
    Vilaca, Tatiane
    Gossiel, Fatma
    Schalkwijk, Casper
    Walsh, Jennifer
    Selvarajah, Dinesh
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 79 - 79
  • [39] The association between dietary and skin advanced glycation end products: the Rotterdam Study
    Chen, Jinluan
    Waqas, Komal
    Carlo Tan, Robby
    Voortman, Trudy
    Ikram, M. Arfan
    Nijsten, Tamar E. C.
    de Groot, Lisette C. P. G. M.
    Uitterlinden, Andre G.
    Zillikens, M. Carola
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 112 (01): : 129 - 137
  • [40] Canadian Diabetes Association National Nutrition Committee Technical Review: Advanced Glycation End-products in Diabetes Management
    Hsu, Doreen
    Zimmer, Victoria
    CANADIAN JOURNAL OF DIABETES, 2010, 34 (02) : 136 - 140